Webinar : Detecting Alzheimer's disease subtypes with proteomics

We are pleased to announce an upcoming webinar in collaboration with Olink, Part of Thermo Fisher, titled “Detecting Alzheimer’s Disease Subtypes with Serum Proteomics”, showcasing how advanced proteomic technologies are reshaping our understanding of Alzheimer’s disease.

Neurological disease research is evolving rapidly, with proteomics offering new insights into disease mechanisms and heterogeneity. This webinar will explore recent advances in CSF and serum proteomics to identify distinct molecular subtypes of Alzheimer’s disease.

Join our upcoming webinar in collaboration with Olink, Part of Thermo Fisher to discover how CSF proteomics is advancing our understanding of Alzheimer’s disease heterogeneity and helping identify underlying molecular subtypes.

During this session, Betty Tijms (Alzheimer Center Amsterdam, Amsterdam UMC) will share recent advances in CSF proteomics and explain how high-throughput protein analysis is enabling researchers to uncover distinct molecular subtypes of Alzheimer’s disease.

How molecular profiling is reshaping our understanding of disease heterogeneity
How high-throughput proteomic analysis can identify distinct biological subtypes of Alzheimer’s disease, including subtypes associated with synaptic function, immune response, vascular integrity, and metabolism
To what extent these Alzheimer’s disease subtypes may also be detectable in blood

– Date: Tuesday, June 9, 2026
– Time: 4:00 PM CEST | 10:00 AM ET

This is a unique opportunity to stay at the forefront of proteomic research and learn how cutting-edge technologies from Olink can enhance your research capabilities.

Register now to secure your spot and join this webinar exploring how serum proteomics is helping identify Alzheimer’s disease subtypes and improve understanding of disease mechanisms.